Andriy Derkach

53PUBLICATIONS
397CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentInfectious diseasesRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Aug 21, 2026
Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 07, 2026
Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Jun 18, 2026
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols.

|Feb 24, 2026
Feasibility of decentralized real-world monitoring of SARS-CoV-2 booster vaccines and COVID-19 outcomes in myeloma.

William A Wood, Shaji K Kumar, Emily Semmel

|Feb 24, 2026
Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach

Pageof 9

Frequent Collaborators

24 joint publications

Kylee Maclachlan

22 joint publications

Malin L Hultcrantz

18 joint publications

Sergio Giralt

18 joint publications

Heather Landau